Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.92 SEK | -6.50% | -12.21% | +33.53% |
Sales 2024 * | 266M 24.47M | Sales 2025 * | 136M 12.48M | Capitalization | 697M 64.14M |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | -72M -6.62M | EV / Sales 2024 * | 1.5 x |
Net cash position 2024 * | 298M 27.38M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.14 x |
P/E ratio 2024 * |
-1.73
x | P/E ratio 2025 * |
-2.89
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.47% |
Latest transcript on Alligator Bioscience AB
1 day | -6.50% | ||
1 week | -12.21% | ||
Current month | -7.44% | ||
1 month | -8.18% | ||
3 months | -21.37% | ||
6 months | +142.11% | ||
Current year | +33.53% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 21-05-31 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 20-08-31 |
Chief Tech/Sci/R&D Officer | 56 | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Graham Dixon
BRD | Director/Board Member | 63 | 19-05-08 |
Chairman | 70 | 16-12-31 | |
Staffan Encrantz
BRD | Director/Board Member | 73 | 22-05-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.92 | -6.50% | 2,734,872 |
24-04-23 | 0.984 | -1.01% | 963,340 |
24-04-22 | 0.994 | -2.36% | 786,608 |
24-04-19 | 1.018 | -2.12% | 597,748 |
24-04-18 | 1.04 | -0.76% | 704,238 |
Delayed Quote Nasdaq Stockholm, April 24, 2024 at 11:29 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.53% | 64.04M | |
+4.09% | 43.84B | |
+47.81% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- ATORX Stock